ArticleCardiovascular diabetology2026
Joint assessment of insulin resistance surrogate indices and basal metabolic rate for primary prevention of cardiometabolic multimorbidity: evidence from the China Health and Retirement Longitudinal Study (2011-2020).
Article in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Technostress and Insulin Resistance Risk: A Cross-Sectional Analysis of 104,175 Spanish Workers Using TyG, TyG-BMI, METS-IR, and SPISE Indices.Medical sciences (Basel, Switzerland) · 2026Article
- Associations of insulin resistance-related indices with the risk and progression of cardiometabolic multimorbidity in individuals with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.Cardiovascular diabetology · 2026Article
- Estimated glucose disposal rate outperforms inflammation surrogate markers in predicting cardiometabolic multimorbidity among middle-aged and older adults.Cardiovascular diabetology · 2026Article
- Association of the C-reactive protein-triglyceride-glucose (CTI) index and its central obesity-modified derivatives with incident cardiometabolic multimorbidity: results from two prospective cohorts in China and England.Cardiovascular diabetology · 2026Article
- The association between triglyceride glucose-frailty index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national prospective cohort study.Cardiovascular diabetology · 2026Article
- Synergistic effects of insulin resistance and revascularization completeness on prognosis in patients with coronary artery calcification.Cardiovascular diabetology · 2026Observational
- Changes in the estimated glucose disposal rate and cardiometabolic multimorbidity in middle-aged and older adults.Cardiovascular diabetology · 2026Article
- Associations of eight insulin resistance-related indices and genetic risk with incident cardiometabolic multimorbidity among participants with hypertension: a large prospective cohort study.Cardiovascular diabetology · 2026Observational
- Triglyceride-glucose related indices, cardiometabolic multimorbidity, and risk of incident osteoarthritis: A prospective cohort study in UK Biobank.Therapeutic advances in musculoskeletal disease · 2026Article
- Joint assessment of white blood cell-to-HDL cholesterol ratio and waist-to-height-hemoglobin A1c for cardiometabolic multimorbidity risk: a prospective cohort study and cross-sectional study.Frontiers in nutrition · 2026Article
- Night shift work exposure shapes neurobehavioral and cardiometabolic profiles in female healthcare workers: a cross-sectional study.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe triglyceride-glucose (TyG) index, estimated glucose disposal rate (eGDR), and metabolic score for insulin resistance (METS-IR) are well-established surrogate indices of insulin resistance (IR). Although both IR and elevated basal metabolic rate (BMR) are recognized risk factors for cardiometabolic diseases, their joint effects on the risk of cardiometabolic multimorbidity (CMM) remain unclear. This study aimed to investigate the separate and combined associations of these IR surrogates and BMR with incident CMM.
methodsWe included 7204 eligible participants from the 2011-2020 survey waves of the China Health and Retirement Longitudinal Study (CHARLS). Participants were stratified by median values of IR surrogate indices and BMR. The associations with CMM were assessed using Kaplan-Meier curves, multivariable Cox regression, and restricted cubic splines (RCS). Predictive performance was evaluated using receiver operating characteristic (ROC) curves, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Mediation and interaction analyses were performed to explore potential underlying relationships.
resultsOver a median follow-up of 9 years, 1103 participants (15.31%) developed CMM. Compared to those with low IR and low BMR, participants with high levels of both exhibited the highest risk of CMM, with hazard ratios of 2.13 (95% CI 1.73-2.63) for TyG, 1.93 (95% CI 1.57-2.36) for eGDR, and 1.92 (95% CI 1.61-2.29) for METS-IR. These associations remained consistent in subgroup and sensitivity analyses. Adding IR indices and BMR to the baseline model significantly improved CMM prediction: TyG (AUC 0.759, NRI 0.371, IDI 0.017; all P < 0.001), eGDR (AUC 0.753, NRI 0.330, IDI 0.012; all P < 0.01), and METS-IR (AUC 0.747, NRI 0.170, IDI 0.004; all P < 0.01). Mediation analysis demonstrated that all IR indices significantly mediated the association between BMR and CMM, and a bidirectional mediation relationship was specifically observed between BMR and the TyG index. Notably, no significant additive or multiplicative interactions were detected.
conclusionIR surrogate indices and BMR independently and jointly predicted the risk of CMM, with IR pathways substantially mediating the effect of BMR. The combined assessment of these parameters may improve CMM risk stratification and guide primary prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.